Literature DB >> 315073

Horizontal postrotatory nystagmus response in female subjects with adolescent idiopathic scoliosis.

G M Jensen, K B Wilson.   

Abstract

Quantitative and qualitative assessment of vestibular function was made in 18 female subjects with adolescent idiopathic scoliosis and a control group of 25 female subjects without scoliosis. The Southern California Postrotary Nystagmus Test, which examines postrotatory nystagmus response, was used to assess the vestibular function of subjects in both groups. The results indicated that subjects with adolescent idiopathic scoliosis had a significantly decreased duration of postrotatory nystagmus as well as irregularities in nystagmus form. The recommendation was made that a neurological examination, including assessment of vestibular function, be incorporated into screening methods for scoliosis.

Entities:  

Mesh:

Year:  1979        PMID: 315073     DOI: 10.1093/ptj/59.10.1226

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  4 in total

1.  Estimation of the centre of mass for the study of postural control in Idiopathic Scoliosis patients: a comparison of two techniques.

Authors:  Karl F Zabjek; Christine Coillard; Charles-H Rivard; François Prince
Journal:  Eur Spine J       Date:  2008-01-08       Impact factor: 3.134

2.  Sensory deprivation and balance control in idiopathic scoliosis adolescent.

Authors:  Martin Simoneau; Nadia Richer; Pierre Mercier; Paul Allard; Nomand Teasdale
Journal:  Exp Brain Res       Date:  2005-11-24       Impact factor: 1.972

3.  Altered sensory-weighting mechanisms is observed in adolescents with idiopathic scoliosis.

Authors:  Martin Simoneau; Pierre Mercier; Jean Blouin; Paul Allard; Normand Teasdale
Journal:  BMC Neurosci       Date:  2006-10-19       Impact factor: 3.288

4.  Asymmetric Unilateral Vestibular Perception in Adolescents With Idiopathic Scoliosis.

Authors:  Emma J Woo; Gunter P Siegmund; Christopher W Reilly; Jean-Sébastien Blouin
Journal:  Front Neurol       Date:  2019-12-03       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.